You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • SAT0161 Fluvastatin treatment prevents the inflammatory/oxidative status linked to the clinical activity of the disease in systemic lupus erythematosus patients

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
SLE, Sjögren’s and APS – etiology, pathogenesis and animal models
SAT0161 Fluvastatin treatment prevents the inflammatory/oxidative status linked to the clinical activity of the disease in systemic lupus erythematosus patients

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014300
Mar 2014500
Apr 2014100
May 2014300
Aug 2014100
Sep 2014100
Oct 2014101
Dec 2014100
Jan 2015100
Mar 2015200
Apr 2015201
May 2015100
Jul 2015200
Aug 2015300
Sep 2015300
Nov 2015100
Jan 2016200
Feb 2016100
Mar 2016100
Apr 2016301
May 20161100
Jun 2016100
Jul 2016400
Aug 2016200
Sep 20161300
Oct 2016200
Nov 2016300
Dec 2016200
Jan 201710035
Feb 2017400
Mar 2017500
Apr 2017100
May 2017100
Jun 20171700
Jul 2017900
Aug 2017600
Sep 20171000
Oct 2017200
Nov 2017400
Dec 2017400
Jan 2018800
Feb 2018101
Mar 20181601
Apr 2018600
May 20181000
Jun 2018200
Jul 2018800
Aug 2018600
Sep 2018400
Oct 2018400
Nov 2018600
Jan 2019200
Feb 2019200
Mar 2019400
May 2019400
Jul 2019400
Aug 2019200
Sep 2019600
Dec 2019200
Feb 2020200
Apr 2020201
May 2020800
Jun 2020600
Jul 2020600
Aug 2020100
Sep 2020801
Oct 2020400
Dec 2020200
Jan 2021400
Mar 2021400
Apr 2021600
Oct 2021700
Nov 20211001
Dec 20211000
Jan 2022600
Feb 2022400
Mar 20221200
Apr 2022400
May 20221200
Jun 2022200
Jul 20221200
Aug 2022600
Sep 20221200
Oct 2022400
Nov 20221200
Dec 20221500
Jan 2023200
Feb 2023600
Mar 20231000
May 2023400
Jun 2023400
Jul 2023600
Aug 2023400
Sep 2023800
Oct 2023300
Nov 20231700
Dec 2023800
Jan 20242000
Feb 2024200
Mar 2024200
Total523043